Genomics Collaborative Inc.
This article was originally published in Start Up
Executive Summary
Genomics Collaborative Inc. looks like two distinct businesses: a functional genomics company in Cambridge, MA and a clinical research organization in Blue Bell, Pennsylvania. But they are really two halves of a single drug discovery company, says Michael Pellini, MD, CEO; one that possesses the analytical tools for genetic association studies and biological analysis and the patient biological samples to back them up.